imatinib mesylate has been researched along with Angiospasm, Intracranial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, M; Imanaka-Yoshida, K; Shiba, M; Suzuki, H; Taki, W; Yoshida, T | 1 |
| Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Matsushima, S; Shiba, M; Shimojo, N; Suzuki, H; Taki, W; Yoshida, T | 2 |
3 other study(ies) available for imatinib mesylate and Angiospasm, Intracranial
| Article | Year |
|---|---|
Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats.
Topics: Animals; Apoptosis; Benzamides; Disease Models, Animal; Imatinib Mesylate; Neurons; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial | 2014 |
Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats.
Topics: Animals; Benzamides; Disease Models, Animal; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial | 2012 |
Role of platelet-derived growth factor in cerebral vasospasm after subarachnoid hemorrhage in rats.
Topics: Animals; Benzamides; Carbon; Carotid Artery, Internal; Coronary Angiography; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Imatinib Mesylate; Male; Neurologic Examination; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2013 |